Posts
CleanTech Vanadium ($CTV.V / $CTVFF): A Fluorspar Play Tied to AI Infrastructure?
I’ve been researching fluorspar recently and came across CleanTech Vanadium. The company is advancing fluorspar projects in the Illinois-Kentucky Fluorspar District (IKFD), historically the source of most U.S. fluorspar production. A few things that caught my attention: • Fluorspar is the primary commercial source of fluorine • Fluorine is required …
$ENTX - Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis (NASDAQ: ENTX)
***Seem Interesting -*** Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis (NASDAQ: ENTX). ***The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total …
The UK’s First Digital Merchant Bank - with RWA Tokenisation
News out of the UK today on the London Stock Exchange - Marechale Capital announced its business combination to become the UK’s first listed Digital Merchant Bank - a process which has been in the works for 3 years https://www.londonstockexchange.com/news-article/MAC/completion-of-acquisitions/17655398 This is a penny stock which is currently trading at …
Asia Broadband (OTCID: AABB) Opens Guadalajara Office to Strengthen Operations Near Its Etzatlán Gold and Silver Processing Plant
Announces the opening of the Company's new offices in Guadalajara, Jalisco, Mexico. This move is designed to strengthen the Company’s regional operations presence in Mexico, as AABB moves forward in implementing strategic growth initiatives. “This is an important step in improving our foundation in Mexico,” commented Company management. “Guadalajara provides …
$RVSN - Rail Vision, on track when none of you are looking. The definitive deal with Berkshire Hathaways Railserve.
Lets go back to 2024, and the wording about their first deal with Railserve, part of Marmon Rail, a Berkshire Hathaway company: "-The contract also includes specific purchase quotas that, if met, provide the customer with exclusivity in the North American industrial railyards switching segment." 2026, Rail Vision is now …
The Lounge
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
$HMR - Uber of Shipping - The Most Undervalued Stock on NASDAQ? 40% Drop Despite a 450% Average Earnings Beat, Now Sitting on Triple Support. Zero Debt, Cash Pile Nearly Majority of Market Cap, CEO Buying Hard, Hormuz Just a Bonus. No Red Flags - Prove Me Wrong.
Quick context for new readers: Each time I have posted, stock has moved 40%+ after each, so you might want to listen.The stock went up 130% from my first post & buy at 80c. I have not sold a single share. Let’s talk about what just happened. Q1 wasn’t a …
Why is $gety overlooked?
Can someone explain to me the bear case for Getty images please, am I wrong to think $gety is currently undervalued? $400m market cap with a 2026 target revenue of $968m and expected EBITDA of $287m they have $3.2b in assets and have deals with OpenAI, perplexity, and NVIDIA. Getty …
Why I’m staying away from BZAI: China exposure + specific short-seller red flags
Not financial advice. I’m not making any accusation of fraud, and I’m not saying the short reports are proven. I’m just explaining why BZAI is outside my risk tolerance. BZAI has an interesting edge AI / AI chip story, but I’m avoiding it mainly for two reasons: heavy China/APAC-linked exposure …
$CUE DD: Multi-Catalyst Immunology Platform With Multiple Shots on Goal 🧬
Been digging into **Cue Biopharma ($CUE)** and it looks like an interesting small-cap biotech setting up for several potential catalysts over the next 6-12 months. **What they do:** Cue is developing precision immunotherapies designed to selectively activate or regulate immune responses across cancer, autoimmune, and allergic diseases. Rather than being …